FDA eases rules for Alzheimer's experiments, hoping to speed treatments for dementia

The U.S. government is making it easier to test new Alzheimer's drugs, hoping to speed progress toward new treatments for the mind-robbing disease. One of every eight people 65 or older in the U.S. has Alzheimer's, the most common form of dementia....More